MAK123
α-Glucosidase Activity Assay Kit
sufficient for 100 colorimetric tests
Synonym(s):
α-Glucosidase Test Kit
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NA.84
UNSPSC Code:
12161503
usage
sufficient for 100 colorimetric tests
detection method
colorimetric
relevant disease(s)
endocrinological disorders, diabetes; neurological disorders
storage temp.
−20°C
Gene Information
human ... GAA(2548)
mouse ... GAA(14387)
rat ... GAA(367562)
Related Categories
General description
α-Glucosidase hydrolyzes carbohydrates by acting on terminal, non-reducing a(1→4)-linked D-glucose residues with the release of D-glucose. Defects in α-glucosidase have been implicated in Pompe disease and diabetes.
Application
α-Glucosidase Activity Assay Kit has been used to measure the activity of a-glucosidase.
Suitable for the detection of α-glucosidase activity in biological samples.
Biochem/physiol Actions
In this assay,α-glucosidase activity is determined by a reaction in which α-glucosidase hydrolyzes p-nitrophenyl-α-D-glucopyranoside resulting in the formation of a colorimetric (405 nm) product, proportional to the α-glucosidase activity present
Features and Benefits
Compatible with high-throughput handling systems.
Storage Class
10 - Combustible liquids
wgk
WGK 2
Regulatory Information
监管及禁止进口产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Structure of human lysosomal acid a-glucosidase?a guide for the treatment of Pompe disease.
Veronique R Z, et al.
Nature Communications, 8(1), 1111-1111 (2017)
Youngse Oh et al.
Molecules (Basel, Switzerland), 26(2) (2021-01-16)
Catalpa pod has been used in traditional medicine for the treatment of diabetes mellitus in South America. Studies on the constituents of Catalpa species have shown that it is rich in iridoids. In the present study, three previously undescribed compounds
Atta-ur-Rahman.
Studies in Natural Products Chemistry, Volume 37 (2017)
Nataliya V Petrova et al.
Dose-response : a publication of International Hormesis Society, 20(2), 15593258221099281-15593258221099281 (2022-05-24)
Nitric oxide (NO) as a vaso- and cardio-protective agent could reduce vasomotor dysfunction in different cardiovascular diseases. One of the current therapeutics targeted at NO availability in the vascular wall are highly diluted antibodies to endothelial NO-synthase (eNOS). This drug
Epigallocatechin gallate affects glucose metabolism and increases fitness and lifespan in Drosophila melanogaster.
Wagner A E, et al.
Oncotarget, 6(31), 30568-30568 (2015)
Related Content
Instructions
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service